Meridian Bioscience, Inc. (28)

Browse by Contract Category

Contracts

Form of Indemnification Agreement (Filed With SEC on July 7, 2022)
Agreement and Plan of Merger, dated as of July 7, 2022, by and among Meridian Bioscience, Inc., SD Biosensor, Inc., Columbus Holding Company, and Madeira Acquisition Corp (Filed With SEC on July 7, 2022)
Offer Letter dated February 8, 2022 (Filed With SEC on February 22, 2022)
Form of Performance-Based Restricted Share Unit Award Agreement (Filed With SEC on February 4, 2022)
Form of Nonqualified Stock Option Agreement (Filed With SEC on November 23, 2021)
Executive Vice President Cash-Based Incentive Compensation Plan for Fiscal Year 2022 (Filed With SEC on February 4, 2022)
Chief Executive Officer Cash-Based Incentive Compensation Plan for Fiscal Year 2022 (Filed With SEC on February 4, 2022)
Form of Time-Based Restricted Share Unit Award Agreement (Filed With SEC on November 23, 2021)
$200,000,000 Revolving Credit Facility, Amended and Restated Credit Agreement by and among Meridian Bioscience, Inc., the Guarantors party thereto, the lenders party thereto, PNC... (Filed With SEC on October 29, 2021)
Chief Executive Officer Cash-Based Incentive Compensation Plan for Fiscal Year 2021 (Filed With SEC on February 5, 2021)
Amendment No. 3 to Share Purchase Agreement dated as of December 21, 2020, between Apres-Demain Inc. (formerly known as GenePOC Inc.), Meridian Bioscience Canada, Inc.,... (Filed With SEC on February 5, 2021)
Amendment to Share Purchase Agreement dated as of June 3, 2019, between Apres-Demain Inc. (formerly known as GenePOC Inc.), Meridian Bioscience Canada, Inc., Apres-Demain SA in... (Filed With SEC on February 5, 2021)
Executive Vice President Cash-Based Incentive Compensation Plan for Fiscal Year 2021 (Filed With SEC on February 5, 2021)
Amendment No. 2 to Share Purchase Agreement dated as of September 29, 2020, between Apres-Demain Inc. (formerly known as GenePOC Inc.), Meridian Bioscience Canada, Inc.,... (Filed With SEC on November 23, 2020)
Form of Nonqualified Stock Option Agreement (Filed With SEC on November 23, 2020)
Form of Time-Based Restricted Share Unit Award Agreement (Filed With SEC on November 23, 2020)
Israeli Appendix to the Meridian Bioscience, Inc. 2012 Stock Incentive Plan dated effective July 10, 2020 (Filed With SEC on November 23, 2020)
Agreement and Plan of Merger, dated as of February 19, 2020, by and among Meridian Bioscience, Inc., APM Trust Shelf 14 Ltd. and Exalenz Bioscience Ltd (Filed With SEC on February 20, 2020)
First Amendment and Consent, dated as of February 19, 2020, by and among Meridian Bioscience, Inc., the guarantors party thereto from time to time, the lenders party thereto from... (Filed With SEC on February 20, 2020)
Voting Agreement, dated as of February 19, 2020, by and between Mori Arkin and Meridian Bioscience, Inc (Filed With SEC on February 20, 2020)
Cash - Based Incentive Compensation Plan for Fiscal 2020 (Filed With SEC on February 7, 2020)
Description of Securities (Filed With SEC on November 26, 2019)
Amended Employment Agreement between Meridian and John P. Kenny dated effective October 1, 2019 (Filed With SEC on November 7, 2019)
Separation Agreement and General Release between Meridian Bioscience, Inc. and Eric S. Rasmussen dated June 21, 2019 (Filed With SEC on June 25, 2019)
Promissory Note dated June 3, 2019 between Meridian Bioscience Canada Inc. and GenePOC Inc (Filed With SEC on June 3, 2019)
Credit Agreement, dated May 24, 2019, between Meridian Bioscience, Inc., as borrower, the Guarantors from time to time party thereto, the Lenders from time to time party thereto,... (Filed With SEC on May 31, 2019)
Share Purchase Agreement dated as of April 29, 2019 by and among GenePOC Inc., Meridian Bioscience Canada Inc., the shareholders of GenePOC Inc., Aprs-Demain Holding SA, as... (Filed With SEC on May 7, 2019)
Separation Agreement And Release dated April 26, 2019 (Filed With SEC on April 30, 2019)